RIABNI

Class [005]
Pharmaceutical preparations for treatment of oncologic, and auto-immune diseases and disorders; pharmaceutical preparations for the treatment of inflammatory diseases and disorders, namely Ankylosing spondylitis, scleroderma, asthma, celiac disease, gout, rheumatoid arthritis, prostatitis, colitis, diverticulitis, glomerulonephritis, hidradenitis, inflammatory bowel disease, Crohn's disease, ulcerative colitis, cystitis, myositis, lupus, mast cell activation syndrome, mastocytosis, otitis, sarcoidosis, transplant rejection, and vasculitis; pharmaceutical preparations for treatment of arthritis; pharmaceutical preparations for treatment of diseases and disorders of the blood, skin, namely dermatitis, eczema, psoriasis, bone marrow, central nervous system, namely brain, movement, ocular motility and spinal cord diseases, immune system and joints; pharmaceutical preparations for treatment of non-Hodgkin's lymphoma (NHL), chronic lymphocytic leukemia (CLL), rheumatoid arthritis (RA), granulomatosis with polyangiitis (GPA), microscopic polyangiitis (MPA), pemphigus vulgaris (PV), multiple sclerosis (MS), and stem cell transplantation